101.74
price down icon2.97%   -3.11
after-market After Hours: 101.39 -0.35 -0.34%
loading
Insmed Inc stock is traded at $101.74, with a volume of 3.95M. It is down -2.97% in the last 24 hours and up +50.66% over the past month. Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
See More
Previous Close:
$104.85
Open:
$105.7
24h Volume:
3.95M
Relative Volume:
1.40
Market Cap:
$17.27B
Revenue:
$381.03M
Net Income/Loss:
$-1.01B
P/E Ratio:
-17.10
EPS:
-5.95
Net Cash Flow:
$-789.25M
1W Performance:
+2.29%
1M Performance:
+50.66%
6M Performance:
+43.96%
1Y Performance:
+47.49%
1-Day Range:
Value
$101.14
$105.80
1-Week Range:
Value
$99.02
$106.83
52-Week Range:
Value
$60.40
$106.83

Insmed Inc Stock (INSM) Company Profile

Name
Name
Insmed Inc
Name
Phone
908-977-9900
Name
Address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Employee
1,271
Name
Twitter
@insmed
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
INSM's Discussions on Twitter

Compare INSM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
INSM
Insmed Inc
101.74 17.27B 381.03M -1.01B -789.25M -5.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.25 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.04 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
254.49 28.51B 3.81B -644.79M -669.77M -6.24

Insmed Inc Stock (INSM) Upgrades & Downgrades

Date Action Analyst Rating Change
May-13-25 Initiated Jefferies Buy
Feb-25-25 Initiated RBC Capital Mkts Outperform
Apr-23-24 Initiated Truist Buy
Feb-15-24 Initiated Wolfe Research Outperform
Dec-08-23 Initiated Wells Fargo Overweight
Nov-20-23 Resumed JP Morgan Overweight
Jul-26-23 Initiated Guggenheim Buy
Dec-09-22 Initiated Mizuho Buy
Dec-07-22 Initiated Barclays Overweight
Nov-18-22 Initiated BofA Securities Buy
Apr-27-22 Initiated Goldman Buy
Dec-06-21 Initiated JP Morgan Overweight
Oct-19-21 Resumed Monness Crespi & Hardt Buy
Oct-19-21 Resumed Morgan Stanley Overweight
Oct-08-21 Initiated Cantor Fitzgerald Overweight
Apr-26-21 Resumed Credit Suisse Outperform
Dec-17-20 Initiated Berenberg Buy
Oct-12-20 Resumed Stifel Buy
Sep-03-19 Initiated Goldman Buy
Apr-09-19 Reiterated H.C. Wainwright Buy
Feb-15-19 Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jan-17-19 Upgrade Goldman Neutral → Buy
Jan-02-19 Initiated Canaccord Genuity Buy
Aug-06-18 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-23-18 Initiated Goldman Neutral
Apr-23-18 Upgrade Credit Suisse Neutral → Outperform
Mar-21-18 Initiated Morgan Stanley Overweight
Jan-18-18 Initiated Credit Suisse Neutral
Sep-05-17 Reiterated Evercore ISI Outperform
Aug-17-17 Initiated Evercore ISI Outperform
Jul-11-17 Initiated Robert W. Baird Outperform
Mar-15-16 Initiated Stifel Buy
Nov-09-15 Downgrade UBS Buy → Neutral
Oct-06-15 Reiterated H.C. Wainwright Buy
Jun-09-15 Initiated Citigroup Neutral
Mar-26-14 Reiterated HC Wainwright Buy
View All

Insmed Inc Stock (INSM) Latest News

pulisher
Jun 18, 2025

Insider Sell: Roger Adsett Sells 10,686 Shares of Insmed Inc (INSM) - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110 - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Is Insmed Stock Overvalued at $98? - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Insider Monkey

Jun 17, 2025
pulisher
Jun 16, 2025

Insmed Completes $750 Million Follow-On Public Offering - Global Legal Chronicle

Jun 16, 2025
pulisher
Jun 16, 2025

Is Insmed Stock Overvalued After The 45% Jump? - Forbes

Jun 16, 2025
pulisher
Jun 15, 2025

Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga

Jun 15, 2025
pulisher
Jun 15, 2025

Insmed Inc (INSM) Soars 30% on Impressive Study - MSN

Jun 15, 2025
pulisher
Jun 13, 2025

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Insider Monkey

Jun 13, 2025
pulisher
Jun 13, 2025

INSM September 19th Options Begin Trading - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Soars After Raising $650 million - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Jumps 29% on Encouraging PAH Study Results - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com

Jun 12, 2025
pulisher
Jun 12, 2025

SEC Form 424B5 filed by Insmed Incorporated - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed prices capital raise of $750 via stock offering - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed announces $650M public offering of common stock - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge - Daily Chhattisgarh News

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed aims to raise $750M in one of the largest stock offerings this year - Endpoints News

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks To Watch: Insmed Sees RS Rating Jump To 93 - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed dips after $750 mln stock sale - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed is an attractive, but expensive takeout meal - statnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

INSM Increases Common Stock Offering to $750M | INSM Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Prices $750 Million Common Stock Offering - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Raises Massive $750M in Stock Offering to Advance Breakthrough Drug Pipeline - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

INSM: Mizuho Raises Price Target for Insmed to $110 | INSM Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Insmed Prices Public Offering Of About 7.81 Mln Shares At $96.00/shr - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed raises $750 million in public offering of common stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing of $750 Million Public Offering of Comm - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed raises $750 million in public offering of common stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing Of $750 Million Public Offering Of Common Stock At $96 Per Share - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing of $750 Million Public Offering of Common Stock - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

These 10 Stocks Are Flying High - Insider Monkey

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Plans $650M Public Offering of Common Stock | INSM - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed's drug for rare lung disease meets main goal in mid-stage trial - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Sees Price Target Boost Amid Strong PAH Data | INS - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Price Target Raised to $120 by HC Wainwright & Co. - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Plans $650M Stock Offering, Shares Fall - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650 million public offering of common stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650 million public offering of common stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Plans $650 Million Public Offering - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650M common stock offering - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Proposed $650 Million Public Offering of Common Stock | INSM Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Sees Boost with Positive Phase 2b Trial Results | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | I - GuruFocus

Jun 11, 2025

Insmed Inc Stock (INSM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Insmed Inc Stock (INSM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Bonstein Sara
Chief Financial Officer
Jun 23 '25
Sale
101.78
57,765
5,879,089
93,536
$21.32
price up icon 0.24%
$35.27
price down icon 1.78%
$20.73
price up icon 1.02%
$106.14
price up icon 1.28%
biotechnology ONC
$254.49
price down icon 4.73%
Cap:     |  Volume (24h):